Endurant Capital Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-13,172
Closed -$340K 74
2020
Q3
$340K Buy
+13,172
New +$340K 0.1% 56
2018
Q2
Sell
-3,785
Closed -$615K 80
2018
Q1
$615K Sell
3,785
-515
-12% -$83.7K 0.23% 63
2017
Q4
$906K Buy
4,300
+832
+24% +$175K 0.28% 60
2017
Q3
$928K Sell
3,468
-987
-22% -$264K 0.28% 69
2017
Q2
$993K Buy
+4,455
New +$993K 0.28% 67